Parkinson’s Disease
145 results.
GRAND RAPIDS, Mich. (April 16, 2024) — A new study from Van Andel Institute scientists offers a first look into the complex molecular changes that occur…
GRAND RAPIDS, Mich. (April 11, 2024) — Van Andel Institute has named pioneering scientist Anders Björklund, M.D., Ph.D., as recipient of its 2024
LONDON (April 3, 2024) — Results from a one-year, phase 2 clinical trial of the Type 2 diabetes drug lixisenatide suggest that the treatment may…
GRAND RAPIDS, Mich. (March 6, 2024) — Van Andel Institute’s free Public Lecture Series returns March 20. This year’s lineup tackles topics such as cancer and nutrition,…
LONDON (Feb. 23, 2024) — Cure Parkinson’s and Van Andel Institute are delighted to announce funding for a Phase 2 clinical trial…
A “blockbuster” weight loss medication hailed as the “2023 Breakthrough of the Year” by Science also may have game-changing implications for Parkinson’s…
GRAND RAPIDS (Mich.) Sept. 29, 2023 — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr. Natasha Fothergill-Misbah, Research…
Parkinson’s disease is a challenging diagnosis. It requires adjustments to day-to-day life and a change in regular habits. But for Richard Cebelak, Parkinson’s would not…